{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"data_sharing_plan":["IPD Sharing (as of September 2018): No"],"condition":["Metastatic Colorectal Cancer","Advanced solid tumors","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Advanced Solid Tumors","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2088653"],"location":["Belgium","United States","Spain"],"study_start_month":["3"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Sym004 in Patients With Advanced Solid Tumors","description":"This trial is designed as a multi-centre, open label, dose-escalation, phase I trial and consists of five parts.","dates":{"creation":"2010-03-15"},"accession":"2088653","cross_references":{"ClinicalTrials___gov":["NCT01117428"],"EU Clinical Trials Register":["2009-017119-13"]}}